Table 2 Characteristics of included studies
Author | Study period | Country | Number of patients with TED | Prevalence (%) hyperthyroidism in TED | Prevalence (%) hypothyroidism in TED | Prevalence (%) euthyroidism in TED |
|---|---|---|---|---|---|---|
Ackuaku-Dogbe et al. [24] | 2014–2016 | Ghana | 117 | 104 (88.9) | 5 (4.3) | 8 (6.8) |
Expósito et al. [25] | 2007–2011 | Spain | 18 | 12 (66.7) | 6 (33.3) | – |
Bartley et al. [14] | 1976–1990 | USA | 120 | 108 (90) | 5 (4.2) | 7 (5.8) |
Eckstein et al. [15] | 2000 | Germany | 182 | 143 (78.6) | 11 (6) | 28 (15.4) |
Jang et al. [26] | 2008–2010 | South Korea | 163 | 139 (85.3) | – | 24 (14.7) |
Kashkouli et al. [22] | 2003–2006 | Iran | 303 | 280 (92.4) | 23 (7.5) | – |
Khoo et al. [27] | 1996–1999 | Singapore | 1020 | 1011 (99.1) | 2 (0.2) | 7 (0.7) |
McKeag et al. [28] | 2006–2007 | Wales | 47 | 44 (93.6) | 3 (6.4) | – |
Medghalchi et al. [29] | 2012–2014 | Iran | 103 | 83 (80.5) | 19 (18.4) | 1 (0.9) |
Mukasa et al. [30] | 2010–2010 | Japan | 238 | 210 (88.2) | – | 28 (11.8) |
Ponto et al. [31] | 1999–2012 | Germany | 610 | 584 (95.7) | – | – |
Ponto et al. [32] | 2005–2012 | Germany | 461 | 441 (95.6) | 12 (2.6) | 8 (1.7) |
Cozma et al. [33] | 1997–2005 | Wales | 140 | 92 (65.7) | 29 (20.7) | 19 (13.6) |